Search hospitals > Michigan > Southfield
Ascension Providence Hospitals - Southfield
Claim this profileSouthfield, Michigan 48075
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
235 reported clinical trials
10 medical researchers
Summary
Ascension Providence Hospitals - Southfield is a medical facility located in Southfield, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Ascension Providence Hospitals - Southfield is involved with conducting 235 clinical trials across 319 conditions. There are 10 research doctors associated with this hospital, such as Susan E. Lyons, Adam M. Forman, Cynthia M. Vakhariya, and Howard R. Terebelo.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Susan E. LyonsAscension Providence Hospitals - Southfield4 years of reported clinical research
Studies Adenocarcinoma
Studies Colorectal Cancer
20 reported clinical trials
39 drugs studied
Adam M. FormanAscension Providence Hospitals - Southfield4 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
40 drugs studied
Cynthia M. VakhariyaAscension Providence Hospitals - Southfield8 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
13 reported clinical trials
27 drugs studied
Howard R. TerebeloAscension Providence Hospitals - Southfield1 year of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
6 reported clinical trials
13 drugs studied
Clinical Trials running at Ascension Providence Hospitals - Southfield
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Pancreatic Cancer
Rectal Cancer
Anal Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Heart Failure
Sacituzumab Govitecan
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) versus treatment of physician's choice (TPC) in participants with previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do not express programmed cell death ligand 1 (PD-L1) or in participants previously treated with anti-programmed cell death (ligand or protein) 1 (Anti-PD-(L)1) Agents in the early setting whose tumors do express PD-L1.
Recruiting4 awards Phase 3
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ascension Providence Hospitals - Southfield?
Ascension Providence Hospitals - Southfield is a medical facility located in Southfield, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Ascension Providence Hospitals - Southfield is involved with conducting 235 clinical trials across 319 conditions. There are 10 research doctors associated with this hospital, such as Susan E. Lyons, Adam M. Forman, Cynthia M. Vakhariya, and Howard R. Terebelo.